Alternative pathway to reduced artemisinin susceptibility in Plasmodium falciparum

PDF) K13-Mediated Reduced Susceptibility to Artemisinin in

Efficacy and safety of artemisinin-based combination therapy and the implications of Pfkelch13 and Pfcoronin molecular markers in treatment failure in Senegal

PDF) Randomised controlled trial of two sequential artemisinin-based combination therapy regimens to treat uncomplicated falciparum malaria in African children: A protocol to investigate safety, efficacy and adherence

Quinoline‐Dihydropyrimidin‐2(1H)‐one Hybrids: Synthesis

PDF) Modification of pfap2μ and pfubp1 Markedly Reduces Ring-Stage Susceptibility of Plasmodium falciparum to Artemisinin In Vitro

PDF) Modification of an atypical clathrin-independent AP-2 adaptin complex of Plasmodium falciparum reduces susceptibility to artemisinin

PDF) Prevalence of potential mediators of artemisinin resistance

Population Modification Using Gene Drive for Reduction of Malaria

The Plasmodium falciparum Artemisinin Susceptibility-Associated AP-2 Adaptin μ Subunit is Clathrin Independent and Essential for Schizont Maturation. - Abstract - Europe PMC